Employer Coverage for Weight-Loss Drugs Rises Sharply, Survey Finds

NEW YORK, June 13 (Reuters) – About one-third of U.S. employer health plans are offering coverage of GLP-1 drugs for both diabetes management and weight loss, up from last year, according to a survey of global employers released on Thursday by the International Foundation of Employee Benefit P...